Antipeptide antibodies against overlapping sequences differentially inhibit human CYP2D6

¹Department of Drug Metabolism, Merck Research Laboratories, West Point, PA 19486, USA.

Drug Metabolism and Disposition: the Biological Fate of Chemicals

|July 1, 1995

Summary

Researchers developed specific antibodies against CYP2D6 using peptide sequences. These antibodies effectively recognized and inhibited CYP2D6 activity, offering a precise tool for studying this important enzyme.

Area of Science:

Biochemistry
Immunology
Pharmacology

Background:

Cytochrome P450 2D6 (CYP2D6) is a crucial enzyme in drug metabolism.
Autoantibodies targeting CYP2D6 are implicated in certain autoimmune conditions.
Developing specific reagents to study CYP2D6 is essential for understanding its role.

Purpose of the Study:

To generate specific antibodies against CYP2D6 using synthetic peptides.
To characterize the recognition and inhibitory capabilities of these antibodies.
To identify a peptide sequence suitable for raising highly specific anti-CYP2D6 antibodies.

Main Methods:

Synthesis of two peptides corresponding to CYP2D6 sequences.
Immunization of rabbits with peptide-keyhole limpet hemocyanin conjugates.
Enzyme-linked immunosorbent assay (ELISA) for immune response assessment.
Western blotting to confirm antibody recognition of CYP2D6.
Inhibition assays using recombinant and human liver microsome CYP2D6 activity.
Cross-reactivity testing against other CYP isoforms.

Main Results:

Peptide conjugates elicited strong immune responses with high antibody titers.
Generated antisera recognized CYP2D6 on Western blots and inhibited its activity.
Antibodies raised against peptide 2 demonstrated the highest inhibitory potency (up to 95% inhibition of dextromethorphan O-demethylase).
Antisera showed high specificity, with no significant cross-reactivity against other major CYP isoforms (CYP1A2, CYP2C9, CYP2E1, CYP3A4).
A strong correlation (r = 0.95) was observed between immunoreactive CYP2D6 levels and enzyme activity.

Conclusions:

Peptide 2 (amino acids 254-273 of CYP2D6) is identified as a key sequence for raising specific and potent inhibitory antibodies against CYP2D6.
These antibodies serve as valuable tools for the specific detection and functional study of CYP2D6 in biological samples.
The findings contribute to the development of diagnostic and research reagents for CYP2D6-related studies.

Related Experiment Videos

Antipeptide antibodies against overlapping sequences differentially inhibit human CYP2D6

Related Concept Videos

Brincidofovir treatment of acyclovir-resistant disseminated varicella zoster virus infection in an immunocompromised host.

Innovation in veterinary medical education: the concept of 'One World, One Health' in the curriculum of the Faculty of Veterinary Medicine at the University of Calgary.

The failure of selenium supplementation to prevent copper-induced liver damage in Fischer 344 rats.

The diffusion of the health agenda and the fundamental need for partnership in medical education.

Effects of carbon tetrachloride-injured hepatocytes on hepatic stellate cell activation and salvianolic acid A preventive action in vitro.

Ribozyme-mediated resistance to rice dwarf virus and the transgene silencing in the progeny of transgenic rice plants.

3D hepatic spheroid arrays for clearance assessment of small and bRo5 molecules.

Modeling cortisol and cortisone binding to corticosteroid-binding globulin and albumin based on clinical protein binding data.

A 3-step static mechanistic modeling approach to predicting transporter- and enzyme-mediated interaction signals of direct oral anticoagulants.

Microfluidic liver-chip to predict clinical drug-drug interaction net effects for precipitant drugs with dual CYP3A4 inhibition and induction potential.

PSMD2 mediates the degradation of CYP1A2 and promotes the progression of metabolic dysfunction-associated steatohepatitis.

A comprehensive investigation into the effect of bisphenol A on the expression of drug-metabolizing enzymes: Consequences for endogenous metabolites and xenobiotic pharmacokinetics.

Phosphoinositide-specific Phospholipase C 2 (SlPLC2) Facilitates Vesicle Formation and Modulates Immune Signaling in Tomato Phytophthora infestans Interactions.

PepOSX-AI: CPP - an interpretable transformer-based deep learning model for prediction of cell-penetrating peptides.

Gelsolin domains G2G3 recruit other domains and prime the actin filament for severing.

Rational design, synthesis, and biological evaluation of novel PARP1 degraders for colon cancer therapy.

Optimizing separation conditions for melittin purification from bee venom using molecular dynamics simulations.

Advances in nucleotide-based P2Y₁ antagonism: implications for cardiovascular therapeutics.

Related Experiment Videos

Antipeptide antibodies against overlapping sequences differentially inhibit human CYP2D6

Area of Science:

Background:

Purpose of the Study:

Main Methods:

Main Results:

Conclusions:

Related Concept Videos

Related Articles